Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Glucagon-like peptide-1 (GLP-1) is an intestinally derived insulinotropic hormone currently under investigation for use as a novel therapeutic agent in the treatment of type 2 diabetes. One of several important effects of GLP-1 is on nutrient-induced pancreatic hormone release and is mediated by bin...
Main Authors: | Gromada, J, Brock, B, Schmitz, O, Rorsman, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
by: Gromada, J, et al.
Published: (2004) -
Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
by: Gromada, J, et al.
Published: (1997) -
Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
by: Gromada, J, et al.
Published: (1998) -
Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.
by: Gromada, J, et al.
Published: (1996) -
Calcium regulation of glucagon-like peptide-1 secretion.
by: Chua, Sharon Chia Ling.
Published: (2010)